FLUVASTATIN

FLUVASTATIN was reported 4472 times

FLUVASTATIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VASCULAR ANASTOMOTIC HAEMORRHAGE 27 0.9000
1 ANTINUCLEAR ANTIBODY NEGATIVE 17 0.4857
2 VENA CAVA INJURY 28 0.3043
3 PERINEAL CYST 22 0.3014
4 PHARYNGEAL NECROSIS 13 0.2826
5 PANCREATIC CYSTADENOMA 11 0.2292
6 BILIARY ANASTOMOSIS 4 0.2222
7 AMAUROSIS FUGAX 231 0.2145
8 RENAL CYST HAEMORRHAGE 36 0.1593
9 CONGENITAL AORTIC DILATATION 3 0.1250
10 FUNGURIA 4 0.1081
11 LIMB HYPOPLASIA CONGENITAL 15 0.1042
12 ANAL CYST 6 0.1034
13 PERITONEAL HERNIA 3 0.0968
14 ARCUS LIPOIDES 6 0.0952
15 ABDOMINAL WALL HAEMORRHAGE 24 0.0920
16 MYOGLOBIN URINE 3 0.0909
17 URETERIC INJURY 10 0.0893
18 INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM 25 0.0825
19 VASCULAR COMPRESSION 25 0.0791
20 CONGENITAL ORAL MALFORMATION 14 0.0639
21 BLOOD 25-HYDROXYCHOLECALCIFEROL DECREASED 16 0.0552
22 DELAYED GRAFT FUNCTION 36 0.0506
23 STERILE PYURIA 3 0.0469
24 LIMB REDUCTION DEFECT 27 0.0462
25 URINARY TRACT DISORDER 204 0.0453
26 HERPES SIMPLEX REACTIVATION 16 0.0420
27 COOMBS POSITIVE HAEMOLYTIC ANAEMIA 17 0.0370
28 CAROTID ARTERIOSCLEROSIS 38 0.0368
29 NECK DEFORMITY 16 0.0360
30 TINEA CAPITIS 4 0.0348
31 GENERAL PHYSICAL CONDITION 4 0.0339
32 INTERVERTEBRAL DISC SPACE NARROWING 27 0.0335
33 HAEMORRHAGIC STROKE 252 0.0322
34 RECTAL PROLAPSE 36 0.0298
35 AORTIC DILATATION 32 0.0288
36 TOOTH DEMINERALISATION 3 0.0286
37 POST 5-ALPHA-REDUCTASE INHIBITOR SYNDROME 8 0.0282
38 DERMATOPHYTOSIS OF NAIL 3 0.0252
39 NEPHROANGIOSCLEROSIS 4 0.0248
40 RENAL ARTERY STENOSIS 33 0.0239
41 RADIATION NECROSIS 13 0.0227
42 OCULAR DISCOMFORT 234 0.0208
43 CAPSULE PHYSICAL ISSUE 3 0.0207
44 PORTAL VEIN OCCLUSION 3 0.0205
45 DEVELOPMENTAL HIP DYSPLASIA 17 0.0204
46 GENERALISED OEDEMA 235 0.0190
47 TRICHOPHYTOSIS 4 0.0189
48 GROSS MOTOR DELAY 5 0.0176
49 EOSINOPHILIC FASCIITIS 6 0.0173
50 MYOSCLEROSIS 6 0.0163
51 GLOMERULONEPHRITIS CHRONIC 3 0.0160
52 PULMONARY ARTERY STENOSIS 6 0.0153
53 AORTIC ARTERIOSCLEROSIS 38 0.0148
54 OCULAR MYASTHENIA 5 0.0146
55 PANCREATIC NECROSIS 5 0.0144
56 SUDDEN VISUAL LOSS 4 0.0143
57 ACTINIC KERATOSIS 37 0.0142
58 MEAN CELL VOLUME INCREASED 36 0.0140
59 HEPATOSPLENOMEGALY 36 0.0140
60 PIERRE ROBIN SYNDROME 3 0.0140
61 IRREGULAR BREATHING 8 0.0136
62 HEAD DISCOMFORT 233 0.0131
63 CLEFT PALATE 25 0.0129
64 MUSCLE DISCOMFORT 10 0.0127
65 TUBERCULOSIS GASTROINTESTINAL 4 0.0125
66 COMPLICATIONS OF TRANSPLANTED KIDNEY 28 0.0123
67 DYSMORPHISM 29 0.0123
68 COMPLEX REGIONAL PAIN SYNDROME 18 0.0122
69 URETERAL DISORDER 5 0.0122
70 NEONATAL SEIZURE 3 0.0120
71 GASTRITIS HAEMORRHAGIC 18 0.0120
72 ALTERED STATE OF CONSCIOUSNESS 234 0.0108
73 ABDOMINAL HERNIA REPAIR 2 0.0108
74 CEREBELLAR HAEMATOMA 3 0.0107
75 AMYOTROPHIC LATERAL SCLEROSIS 23 0.0107
76 ANTIPHOSPHOLIPID SYNDROME 17 0.0106
77 REACTIVE GASTROPATHY 4 0.0104
78 HYPERPARATHYROIDISM SECONDARY 25 0.0100
79 PRESYNCOPE 242 0.0099
80 SYSTEMIC INFECTION 16 0.0096
81 VENTRICULAR FAILURE 3 0.0096
82 HAEMATEMESIS 240 0.0095
83 MYOGLOBINURIA 5 0.0094
84 DIVERTICULUM INTESTINAL 41 0.0094
85 LEFT VENTRICULAR HYPERTROPHY 40 0.0093
86 PHOTOPHOBIA 174 0.0092
87 NECROTISING MYOSITIS 8 0.0092
88 GASTROENTERITIS CLOSTRIDIAL 3 0.0085
89 SPINAL STENOSIS 35 0.0085
90 CENTRAL OBESITY 6 0.0081
91 MYOPATHY 70 0.0081
92 TALIPES 25 0.0080
93 PERIORAL DERMATITIS 5 0.0079
94 ASCITES 231 0.0079
95 ABDOMINAL COMPARTMENT SYNDROME 5 0.0078
96 DIPLOPIA 203 0.0078
97 INVASIVE LOBULAR BREAST CARCINOMA 4 0.0078
98 AORTIC VALVE CALCIFICATION 4 0.0078
99 APLASIA 15 0.0077
100 FASCIITIS 5 0.0076
101 CONVULSION NEONATAL 4 0.0076
102 OBSTRUCTIVE UROPATHY 3 0.0074
103 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 37 0.0073
104 PATENT DUCTUS ARTERIOSUS 29 0.0073
105 GASTROINTESTINAL ANGIODYSPLASIA 3 0.0073
106 BENIGN PROSTATIC HYPERPLASIA 37 0.0072
107 ORAL MUCOSAL ERUPTION 11 0.0072
108 CONGENITAL MUSCULOSKELETAL ANOMALY 3 0.0068
109 MUSCLE NECROSIS 6 0.0066
110 HAEMATURIA 220 0.0064
111 CHRONIC ALLOGRAFT NEPHROPATHY 5 0.0064
112 GASTRIC VARICES 3 0.0064
113 HYPERPARATHYROIDISM 13 0.0063
114 PLEURITIC PAIN 17 0.0062
115 SQUAMOUS CELL CARCINOMA OF SKIN 37 0.0061
116 GLOMERULAR FILTRATION RATE INCREASED 5 0.0061
117 TINEA CRURIS 3 0.0060
118 ANXIETY DISORDER 20 0.0060
119 ACQUIRED OESOPHAGEAL WEB 2 0.0059
120 AORTIC VALVE INCOMPETENCE 25 0.0059
121 BLINDNESS 238 0.0058
122 DIABETIC METABOLIC DECOMPENSATION 8 0.0058
123 CARDIO-RESPIRATORY ARREST 240 0.0057
124 PROPOFOL INFUSION SYNDROME 4 0.0057
125 ORTHOSTATIC INTOLERANCE 4 0.0056
126 BRADYCARDIA NEONATAL 7 0.0056
127 PALMOPLANTAR KERATODERMA 4 0.0055
128 HAEMOCHROMATOSIS 5 0.0054
129 MYOGLOBIN BLOOD INCREASED 8 0.0052
130 AMYOTROPHY 2 0.0052
131 AORTIC CALCIFICATION 3 0.0052
132 COMA 240 0.0050
133 RESPIRATORY TRACT HAEMORRHAGE 3 0.0050
134 GOUTY ARTHRITIS 4 0.0050
135 BLOOD CREATINE PHOSPHOKINASE INCREASED 144 0.0050
136 GAMMA-GLUTAMYLTRANSFERASE ABNORMAL 3 0.0050
137 ALVEOLITIS 7 0.0050
138 FEBRILE BONE MARROW APLASIA 21 0.0049
139 CHOLESTATIC LIVER INJURY 11 0.0049
140 NEURODEGENERATIVE DISORDER 3 0.0049
141 ATRIOVENTRICULAR BLOCK FIRST DEGREE 21 0.0048
142 CHOLANGIOCARCINOMA 7 0.0047
143 TINNITUS 213 0.0046
144 OESOPHAGEAL SPASM 8 0.0043
145 TEMPORAL ARTERITIS 4 0.0043
146 PAROTITIS 5 0.0043
147 WALKING DISABILITY 9 0.0043
148 URINARY TRACT INFECTION ENTEROCOCCAL 4 0.0043
149 EYE PAIN 240 0.0042
150 FEBRILE INFECTION 5 0.0042
151 AIR EMBOLISM 2 0.0042
152 ATRIAL SEPTAL DEFECT 35 0.0042
153 REFLUX GASTRITIS 5 0.0042
154 SPINAL OSTEOARTHRITIS 36 0.0041
155 MYALGIA 688 0.0040
156 SWELLING OF EYELID 25 0.0040
157 CUTANEOUS T-CELL LYMPHOMA 5 0.0040
158 POLYMYOSITIS 7 0.0040
159 FEAR OF DISEASE 7 0.0039
160 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 13 0.0039
161 ARTERIOSCLEROSIS 37 0.0039
162 MUSCLE RUPTURE 15 0.0038
163 LARGE INTESTINE POLYP 26 0.0037
164 ATYPICAL PNEUMONIA 11 0.0037
165 ERYSIPELAS 18 0.0036
166 LIPIDS INCREASED 7 0.0035
167 PULMONARY SEPSIS 5 0.0034
168 VASCULAR DEMENTIA 3 0.0034
169 NORMOCYTIC ANAEMIA 5 0.0034
170 DYSLIPIDAEMIA 17 0.0033
171 AUTOIMMUNE HEPATITIS 23 0.0033
172 RENAL CYST 26 0.0033
173 CALCIPHYLAXIS 6 0.0033
174 DIABETIC RETINOPATHY 11 0.0032
175 COLON ADENOMA 3 0.0030
176 BRADYARRHYTHMIA 5 0.0030
177 BLOOD POTASSIUM INCREASED 49 0.0030
178 ATRIOVENTRICULAR BLOCK 23 0.0030
179 LARYNGOSPASM 8 0.0030
180 HYPOCHROMIC ANAEMIA 3 0.0030
181 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 12 0.0029
182 GAMMA-GLUTAMYLTRANSFERASE INCREASED 65 0.0029
183 VITAMIN D DECREASED 25 0.0029
184 HEPATIC NECROSIS 11 0.0029
185 TACHYCARDIA 256 0.0029
186 PAPILLARY THYROID CANCER 5 0.0029
187 FACIAL PARESIS 10 0.0028
188 AORTIC VALVE STENOSIS 5 0.0028
189 MONOPARESIS 5 0.0028
190 DYSPNOEA AT REST 8 0.0028
191 ACINETOBACTER INFECTION 3 0.0027
192 KIDNEY TRANSPLANT REJECTION 13 0.0027
193 BLOOD IRON INCREASED 5 0.0027
194 BASAL CELL CARCINOMA 41 0.0026
195 BREAST SWELLING 7 0.0026
196 PNEUMOCYSTIS JIROVECII PNEUMONIA 26 0.0026
197 CARDIAC FAILURE CHRONIC 11 0.0026
198 PULMONARY FUNCTION TEST ABNORMAL 4 0.0026
199 MEGACOLON 4 0.0025
200 NEPHROCALCINOSIS 3 0.0025
201 PREMATURE RUPTURE OF MEMBRANES 6 0.0025
202 SYNCOPE 249 0.0025
203 RESTLESS LEGS SYNDROME 45 0.0025
204 HEPATIC STEATOSIS 46 0.0025
205 SEPSIS 271 0.0024
206 HYPOGLYCAEMIC COMA 7 0.0024
207 PANCREATITIS ACUTE 54 0.0024
208 SYSTEMIC CANDIDA 6 0.0024
209 SEROMA 3 0.0024
210 RHABDOMYOLYSIS 98 0.0023
211 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 3 0.0023
212 PHLEBITIS 12 0.0023
213 ANGINA UNSTABLE 15 0.0023
214 CARDIOACTIVE DRUG LEVEL INCREASED 3 0.0023
215 HYPERLIPIDAEMIA 27 0.0023
216 ANION GAP INCREASED 3 0.0022
217 BLOOD UREA INCREASED 37 0.0022
218 CHILLS 257 0.0022
219 PANCREATITIS NECROTISING 5 0.0022
220 PERIPHERAL ARTERY THROMBOSIS 3 0.0021
221 BILE DUCT OBSTRUCTION 4 0.0021
222 ANTINUCLEAR ANTIBODY INCREASED 2 0.0021
223 HAEMORRHOIDS 40 0.0020
224 CAROTID ARTERY STENOSIS 7 0.0020
225 VENTRICULAR HYPERTROPHY 5 0.0020
226 DISSEMINATED TUBERCULOSIS 5 0.0019
227 TONGUE BITING 4 0.0019
228 PERONEAL NERVE PALSY 11 0.0019
229 BUNDLE BRANCH BLOCK LEFT 8 0.0019
230 WHITE BLOOD CELL DISORDER 5 0.0019
231 ANTINUCLEAR ANTIBODY POSITIVE 6 0.0018
232 GLYCOSYLATED HAEMOGLOBIN INCREASED 46 0.0018
233 THERAPEUTIC AGENT TOXICITY 6 0.0018
234 MYOCARDIAL NECROSIS MARKER INCREASED 3 0.0018
235 FEAR OF DEATH 4 0.0018
236 CYTOMEGALOVIRUS COLITIS 4 0.0017
237 ACUTE PRERENAL FAILURE 2 0.0017
238 METABOLIC ACIDOSIS 55 0.0017
239 PSEUDOMONAL SEPSIS 3 0.0017
240 HEPATITIS ACUTE 11 0.0017
241 TRANSPLANT DYSFUNCTION 3 0.0017
242 BLOOD PRESSURE FLUCTUATION 40 0.0017
243 EMERGENCY CARE 5 0.0016
244 DERMAL CYST 4 0.0016
245 GASTRIC ULCER HAEMORRHAGE 9 0.0016
246 TENDON RUPTURE 20 0.0016
247 MONOPLEGIA 7 0.0016
248 OLIGURIA 10 0.0016
249 ANGINA PECTORIS 46 0.0016
250 TACHYARRHYTHMIA 4 0.0016
251 BLOOD PRESSURE INCREASED 245 0.0016
252 FACE OEDEMA 27 0.0016
253 HEMIPARESIS 27 0.0016
254 CORONARY ARTERY STENOSIS 8 0.0016
255 BLOOD BICARBONATE DECREASED 3 0.0016
256 PULMONARY HYPERTENSION 33 0.0016
257 TESTICULAR PAIN 5 0.0016
258 DUODENAL ULCER 11 0.0016
259 LYMPHOPENIA 22 0.0016
260 CEREBRAL ISCHAEMIA 8 0.0016
261 HAEMOLYSIS 12 0.0016
262 DRUG INTERACTION 243 0.0015
263 BICYTOPENIA 3 0.0015
264 BUNDLE BRANCH BLOCK RIGHT 7 0.0015
265 FEAR 41 0.0015
266 BLOOD CHOLESTEROL ABNORMAL 7 0.0015
267 C-REACTIVE PROTEIN INCREASED 55 0.0015
268 POLYNEUROPATHY 18 0.0015
269 RENAL HAEMORRHAGE 3 0.0015
270 TRIGGER FINGER 6 0.0015
271 OSTEOLYSIS 3 0.0015
272 BLOOD PHOSPHORUS INCREASED 4 0.0015
273 RENAL FAILURE ACUTE 62 0.0015
274 MUSCULOSKELETAL DISCOMFORT 25 0.0015
275 TACHYPHRENIA 5 0.0014
276 DERMATITIS EXFOLIATIVE GENERALISED 5 0.0014
277 RENAL CELL CARCINOMA 7 0.0014
278 DILATATION VENTRICULAR 3 0.0014
279 DIABETIC NEUROPATHY 7 0.0014
280 ORGANISING PNEUMONIA 7 0.0014
281 ANAEMIA MACROCYTIC 3 0.0014
282 RED BLOOD CELL COUNT DECREASED 40 0.0014
283 JAW FRACTURE 3 0.0014
284 LACTIC ACIDOSIS 45 0.0014
285 MOUTH SWELLING 8 0.0014
286 GASTROINTESTINAL NECROSIS 4 0.0014
287 CUTANEOUS VASCULITIS 5 0.0014
288 BRADYCARDIA 72 0.0014
289 PARESIS 3 0.0013
290 MIXED LIVER INJURY 4 0.0013
291 VISION BLURRED 182 0.0013
292 ATRIOVENTRICULAR BLOCK SECOND DEGREE 4 0.0013
293 HYPERKALAEMIA 46 0.0013
294 LIPASE INCREASED 10 0.0013
295 INTRACARDIAC THROMBUS 4 0.0013
296 CORONARY ARTERY DISEASE 39 0.0013
297 ERYTHEMA MULTIFORME 12 0.0013
298 HEPATIC FUNCTION ABNORMAL 48 0.0013
299 BILIRUBIN CONJUGATED INCREASED 3 0.0013
300 CYTOMEGALOVIRUS INFECTION 21 0.0013
301 FAECAL INCONTINENCE 6 0.0012
302 PULSE ABNORMAL 3 0.0012
303 INTERSTITIAL LUNG DISEASE 60 0.0012
304 ADRENAL INSUFFICIENCY 15 0.0012
305 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4 0.0012
306 MYOCARDIAL ISCHAEMIA 14 0.0012
307 MYOSITIS 11 0.0012
308 POLYURIA 10 0.0012
309 HYPERVOLAEMIA 6 0.0012
310 CATHETER SITE HAEMORRHAGE 3 0.0012
311 ABDOMINAL PAIN 278 0.0012
312 CEREBRAL HAEMATOMA 4 0.0012
313 DECREASED APPETITE 275 0.0012
314 HEPATIC CYST 4 0.0012
315 ATRIAL FIBRILLATION 114 0.0012
316 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 12 0.0012
317 DYSURIA 43 0.0012
318 MENOPAUSE 3 0.0012
319 HEPATITIS TOXIC 3 0.0012
320 TORSADE DE POINTES 9 0.0011
321 IMMOBILE 5 0.0011
322 HAEMORRHAGIC ANAEMIA 5 0.0011
323 JAUNDICE CHOLESTATIC 4 0.0011
324 RESTLESSNESS 41 0.0011
325 BLOOD CREATININE INCREASED 73 0.0011
326 SOMNOLENCE 225 0.0011
327 JAUNDICE 30 0.0011
328 ABDOMINAL PAIN UPPER 229 0.0011
329 BRADYPNOEA 3 0.0011
330 MUSCLE DISORDER 9 0.0011
331 ASPARTATE AMINOTRANSFERASE INCREASED 58 0.0011
332 DRUG LEVEL ABOVE THERAPEUTIC 5 0.0011
333 VITREOUS HAEMORRHAGE 3 0.0011
334 ACUTE RESPIRATORY DISTRESS SYNDROME 19 0.0011
335 PERITONITIS 22 0.0011
336 ALANINE AMINOTRANSFERASE INCREASED 65 0.0011
337 SUPRAVENTRICULAR TACHYCARDIA 10 0.0010
338 VASCULAR GRAFT 3 0.0010
339 ESCHERICHIA SEPSIS 3 0.0010
340 OPTIC ISCHAEMIC NEUROPATHY 4 0.0010
341 RALES 6 0.0010
342 INSOMNIA 274 0.0010
343 DRUG LEVEL INCREASED 17 0.0010
344 ABDOMINAL WALL HAEMATOMA 2 0.0010
345 VENOUS THROMBOSIS 4 0.0010
346 BLOOD TRIGLYCERIDES INCREASED 18 0.0010
347 ACUTE MYOCARDIAL INFARCTION 30 0.0010
348 CEREBRAL ATROPHY 4 0.0010
349 HYPOTHYROIDISM 32 0.0010
350 VERTIGO 61 0.0010
351 GASTROINTESTINAL PAIN 11 0.0010
352 NORMOCHROMIC NORMOCYTIC ANAEMIA 3 0.0010
353 PREMATURE BABY 30 0.0010
354 GENERAL PHYSICAL HEALTH DETERIORATION 115 0.0010
355 INTERNATIONAL NORMALISED RATIO DECREASED 4 0.0010
356 INGUINAL HERNIA 6 0.0010
357 FALL 327 0.0010
358 PERIPHERAL ISCHAEMIA 4 0.0010
359 UROSEPSIS 9 0.0010
360 HICCUPS 8 0.0010
361 ACUTE CORONARY SYNDROME 8 0.0010
362 CONGESTIVE CARDIOMYOPATHY 4 0.0010
363 MAJOR DEPRESSION 7 0.0010
364 DRUG-INDUCED LIVER INJURY 30 0.0010
365 RENAL IMPAIRMENT 80 0.0010
366 HALLUCINATIONS, MIXED 4 0.0010
367 CARDIOMYOPATHY 14 0.0009
368 INTERNATIONAL NORMALISED RATIO INCREASED 27 0.0009
369 BLOOD LACTATE DEHYDROGENASE INCREASED 15 0.0009
370 CHOLESTASIS 18 0.0009
371 COUGH 262 0.0009
372 FAECALOMA 5 0.0009
373 CHRONIC KIDNEY DISEASE 69 0.0009
374 OTITIS MEDIA 3 0.0009
375 VENTRICULAR FIBRILLATION 10 0.0009
376 SKIN DISORDER 30 0.0009
377 LEFT VENTRICULAR DYSFUNCTION 6 0.0009
378 HYPOKINESIA 13 0.0009
379 MACULAR OEDEMA 5 0.0009
380 PYREXIA 308 0.0009
381 COLITIS ISCHAEMIC 6 0.0009
382 LEUKOCYTOSIS 16 0.0009
383 TRICUSPID VALVE INCOMPETENCE 7 0.0009
384 CIRCULATORY COLLAPSE 15 0.0009
385 ABDOMINAL HERNIA 4 0.0009
386 BRONCHOPNEUMONIA 3 0.0009
387 NEPHROTIC SYNDROME 6 0.0009
388 TRANSPLANT REJECTION 7 0.0009
389 LEFT VENTRICULAR FAILURE 3 0.0009
390 SHOCK 20 0.0009
391 MYASTHENIA GRAVIS 7 0.0009
392 BLOOD URIC ACID INCREASED 5 0.0009
393 MICTURITION DISORDER 3 0.0009
394 MUSCLE TIGHTNESS 14 0.0009
395 AORTIC STENOSIS 3 0.0009
396 DEFAECATION URGENCY 6 0.0009
397 ANOREXIA 11 0.0009
398 MUSCLE CONTRACTIONS INVOLUNTARY 3 0.0009
399 THROMBOTIC THROMBOCYTOPENIC PURPURA 3 0.0009
400 HAEMATOMA 22 0.0008
401 HAEMORRHAGE SUBCUTANEOUS 3 0.0008
402 SYSTEMIC LUPUS ERYTHEMATOSUS 30 0.0008
403 THIRST 15 0.0008
404 PROTHROMBIN TIME PROLONGED 5 0.0008
405 NON-SMALL CELL LUNG CANCER 4 0.0008
406 HAEMODIALYSIS 7 0.0008
407 PRURITUS 318 0.0008
408 SCLERODERMA 3 0.0008
409 IMMUNE-MEDIATED ENTEROCOLITIS 3 0.0008
410 AMYLASE INCREASED 3 0.0008
411 BLOOD PRESSURE DIASTOLIC DECREASED 6 0.0008
412 HYPERCALCAEMIA 10 0.0008
413 TRANSAMINASES INCREASED 18 0.0008
414 CHOLANGITIS 5 0.0008
415 MALNUTRITION 9 0.0008
416 CORONARY ARTERY OCCLUSION 11 0.0008
417 URINE OUTPUT DECREASED 7 0.0008
418 ARTHRALGIA 329 0.0008
419 DIABETES MELLITUS INADEQUATE CONTROL 14 0.0008
420 FACE INJURY 3 0.0008
421 COORDINATION ABNORMAL 11 0.0008
422 FEMORAL NECK FRACTURE 4 0.0008
423 HAEMOGLOBIN DECREASED 80 0.0008
424 MOVEMENT DISORDER 25 0.0008
425 DIALYSIS 11 0.0008
426 LOW DENSITY LIPOPROTEIN INCREASED 6 0.0008
427 ELECTROLYTE IMBALANCE 9 0.0008
428 VENTRICULAR EXTRASYSTOLES 8 0.0008
429 SUBDURAL HAEMATOMA 11 0.0008
430 BLOOD ALKALINE PHOSPHATASE INCREASED 19 0.0008
431 DIZZINESS 381 0.0008
432 ASTHENIA 287 0.0008
433 POLYDIPSIA 3 0.0008
434 IRON DEFICIENCY ANAEMIA 7 0.0008
435 ACUTE KIDNEY INJURY 116 0.0008
436 BREAST PAIN 8 0.0007
437 VITAMIN B12 DEFICIENCY 3 0.0007
438 LEUKOPENIA 37 0.0007
439 CHEILITIS 4 0.0007
440 GENERAL PHYSICAL CONDITION ABNORMAL 5 0.0007
441 CEREBRAL INFARCTION 18 0.0007
442 PROTEINURIA 14 0.0007
443 TACHYPNOEA 10 0.0007
444 SEPTIC SHOCK 32 0.0007
445 GASTROOESOPHAGEAL REFLUX DISEASE 59 0.0007
446 MUSCLE SPASMS 134 0.0007
447 SINUS BRADYCARDIA 7 0.0007
448 TENDONITIS 11 0.0007
449 CHROMATURIA 16 0.0007
450 BLOOD CHOLESTEROL INCREASED 33 0.0007
451 ESCHERICHIA URINARY TRACT INFECTION 3 0.0007
452 HEPATITIS 18 0.0007
453 MUSCULAR WEAKNESS 79 0.0007
454 HORDEOLUM 3 0.0007
455 PARAESTHESIA ORAL 10 0.0007
456 ABASIA 17 0.0007
457 SLEEP APNOEA SYNDROME 13 0.0007
458 STEVENS-JOHNSON SYNDROME 15 0.0007
459 HYPOKALAEMIA 31 0.0007
460 EAR PAIN 13 0.0007
461 VENTRICULAR TACHYCARDIA 11 0.0007
462 TYPE 1 DIABETES MELLITUS 4 0.0007
463 PEMPHIGOID 5 0.0007
464 CLOSTRIDIUM DIFFICILE COLITIS 7 0.0007
465 HEPATOCELLULAR CARCINOMA 5 0.0007
466 LUMBAR VERTEBRAL FRACTURE 3 0.0007
467 ACIDOSIS 5 0.0007
468 LIVER DISORDER 29 0.0007
469 SLEEP DISORDER 46 0.0007
470 RENAL FAILURE CHRONIC 5 0.0006
471 INTERVERTEBRAL DISC DEGENERATION 6 0.0006
472 CONCOMITANT DISEASE AGGRAVATED 4 0.0006
473 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 5 0.0006
474 GASTRITIS EROSIVE 3 0.0006
475 MALAISE 282 0.0006
476 OSTEONECROSIS 21 0.0006
477 HYPOGLYCAEMIA 31 0.0006
478 SKIN TIGHTNESS 3 0.0006
479 ELECTROCARDIOGRAM ABNORMAL 5 0.0006
480 MELAENA 14 0.0006
481 HEPATOCELLULAR INJURY 9 0.0006
482 DYSPNOEA 356 0.0006
483 ATRIAL FLUTTER 5 0.0006
484 HAEMOGLOBIN ABNORMAL 4 0.0006
485 SWELLING 58 0.0006
486 MITRAL VALVE INCOMPETENCE 7 0.0006
487 VOMITING 290 0.0006
488 BLOOD PRESSURE SYSTOLIC INCREASED 12 0.0006
489 SHOCK HAEMORRHAGIC 5 0.0006
490 LIVER INJURY 15 0.0006
491 DYSPNOEA EXERTIONAL 23 0.0006
492 BREATH SOUNDS ABNORMAL 3 0.0006
493 MYOCARDIAL INFARCTION 106 0.0006
494 PRODUCT FORMULATION ISSUE 4 0.0006
495 ANEURYSM 3 0.0006
496 POST PROCEDURAL HAEMORRHAGE 7 0.0006
497 HYPOTONIA 6 0.0006
498 CARDIAC FAILURE 48 0.0006
499 DISTURBANCE IN ATTENTION 32 0.0006
500 DIARRHOEA 381 0.0006
501 ANGIOEDEMA 26 0.0006
502 MYOCLONUS 7 0.0006
503 ECCHYMOSIS 4 0.0006
504 PSEUDOMONAS INFECTION 5 0.0006
505 DISORIENTATION 23 0.0006
506 HYPERBILIRUBINAEMIA 6 0.0006
507 ANAEMIA 110 0.0006
508 GLOMERULAR FILTRATION RATE DECREASED 7 0.0006
509 POLYARTHRITIS 3 0.0006
510 CARDIOMEGALY 7 0.0006
511 PANCREATITIS 30 0.0006
512 OEDEMA PERIPHERAL 69 0.0006
513 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 5 0.0006
514 PHARYNGOLARYNGEAL PAIN 3 0.0006
515 RETINAL HAEMORRHAGE 4 0.0006
516 THROMBOSIS 45 0.0006
517 MUSCLE ATROPHY 7 0.0006
518 HYDROCEPHALUS 3 0.0006
519 LIVER FUNCTION TEST ABNORMAL 16 0.0005
520 HEPATIC CYTOLYSIS 7 0.0005
521 INTESTINAL ISCHAEMIA 3 0.0005
522 DEAFNESS UNILATERAL 3 0.0005
523 COAGULOPATHY 9 0.0005
524 BODY TEMPERATURE INCREASED 11 0.0005
525 INTRACRANIAL PRESSURE INCREASED 3 0.0005
526 PERSONALITY CHANGE 5 0.0005
527 ANGIOPATHY 3 0.0005
528 FISTULA 6 0.0005
529 JOINT STIFFNESS 14 0.0005
530 SQUAMOUS CELL CARCINOMA 5 0.0005
531 HEADACHE 333 0.0005
532 PREMATURE LABOUR 3 0.0005
533 ADVERSE REACTION 7 0.0005
534 MICTURITION URGENCY 6 0.0005
535 CARDIAC VALVE DISEASE 3 0.0005
536 KNEE ARTHROPLASTY 11 0.0005
537 PNEUMONIA ASPIRATION 13 0.0005
538 ACUTE RESPIRATORY FAILURE 10 0.0005
539 HYPERCHOLESTEROLAEMIA 5 0.0005
540 CONGENITAL ANOMALY 4 0.0005
541 METABOLIC DISORDER 3 0.0005
542 STRESS CARDIOMYOPATHY 3 0.0005
543 LUNG INFECTION 8 0.0005
544 HYPONATRAEMIA 29 0.0005
545 HYPOALBUMINAEMIA 4 0.0005
546 PNEUMONITIS 14 0.0005
547 CEREBROVASCULAR ACCIDENT 87 0.0005
548 HYPOVOLAEMIA 3 0.0005
549 PRODUCT PRESCRIBING ERROR 12 0.0005
550 LOW BIRTH WEIGHT BABY 4 0.0005
551 CARDIAC PACEMAKER INSERTION 3 0.0005
552 OBESITY 8 0.0005
553 GOUT 9 0.0005
554 HEPATITIS CHOLESTATIC 3 0.0005
555 BURSITIS 6 0.0005
556 HEPATOTOXICITY 11 0.0005
557 HYPOTHERMIA 5 0.0005
558 SWELLING FACE 32 0.0005
559 DECUBITUS ULCER 4 0.0005
560 CARDIOGENIC SHOCK 7 0.0005
561 INITIAL INSOMNIA 5 0.0005
562 DRUG INTOLERANCE 47 0.0005
563 ESCHERICHIA INFECTION 4 0.0005
564 HYPERTHYROIDISM 7 0.0005
565 MIDDLE INSOMNIA 9 0.0005
566 EOSINOPHIL COUNT INCREASED 4 0.0005
567 TENDERNESS 5 0.0005
568 URINARY INCONTINENCE 14 0.0005
569 RENAL PAIN 5 0.0005
570 LIVER FUNCTION TEST INCREASED 10 0.0005
571 CARDIAC MURMUR 4 0.0005
572 WOUND INFECTION 5 0.0005
573 BLOOD CALCIUM INCREASED 4 0.0005
574 GASTRITIS 12 0.0005
575 PULMONARY CONGESTION 6 0.0005
576 HAEMATOCRIT DECREASED 9 0.0005
577 PURPURA 4 0.0005
578 CARDIAC FAILURE ACUTE 3 0.0004
579 NAUSEA 356 0.0004
580 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0004
581 COLITIS ULCERATIVE 20 0.0004
582 CEREBRAL HAEMORRHAGE 16 0.0004
583 INTESTINAL PERFORATION 5 0.0004
584 JOINT EFFUSION 3 0.0004
585 CARDIOVASCULAR DISORDER 11 0.0004
586 FORMICATION 3 0.0004
587 APHASIA 13 0.0004
588 EYELID OEDEMA 5 0.0004
589 RENAL FAILURE 57 0.0004
590 NEPHROPATHY 4 0.0004
591 RIGHT VENTRICULAR FAILURE 3 0.0004
592 DIVERTICULUM 3 0.0004
593 HYPERTENSION 89 0.0004
594 FATIGUE 325 0.0004
595 ELECTROCARDIOGRAM QT PROLONGED 15 0.0004
596 DIZZINESS POSTURAL 4 0.0004
597 PLEURAL EFFUSION 25 0.0004
598 AUTOIMMUNE DISORDER 4 0.0004
599 PARKINSONISM 4 0.0004
600 RENAL TUBULAR NECROSIS 4 0.0004
601 HEPATOMEGALY 4 0.0004
602 BODY TEMPERATURE DECREASED 4 0.0004
603 MULTI-ORGAN FAILURE 7 0.0004
604 RASH MACULO-PAPULAR 9 0.0004
605 THROMBOCYTOPENIA 45 0.0004
606 ORTHOSTATIC HYPOTENSION 7 0.0004
607 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 3 0.0004
608 HYPOAESTHESIA ORAL 6 0.0004
609 TOXIC SKIN ERUPTION 4 0.0004
610 ABDOMINAL PAIN LOWER 10 0.0004
611 DRUG ERUPTION 7 0.0004
612 AORTIC ANEURYSM 3 0.0004
613 HAEMODYNAMIC INSTABILITY 3 0.0004
614 SUBARACHNOID HAEMORRHAGE 4 0.0004
615 MATERNAL DRUGS AFFECTING FOETUS 3 0.0004
616 BLOOD PRESSURE DECREASED 26 0.0004
617 MUSCLE TWITCHING 9 0.0004
618 PHARYNGEAL OEDEMA 6 0.0004
619 HELICOBACTER INFECTION 4 0.0004
620 OEDEMA 21 0.0004
621 TYPE 2 DIABETES MELLITUS 13 0.0004
622 EJECTION FRACTION DECREASED 6 0.0004
623 DRUG EFFECT INCOMPLETE 14 0.0004
624 PELVIC FRACTURE 3 0.0004
625 HYPOTENSION 77 0.0004
626 DEHYDRATION 51 0.0004
627 ARTERIAL OCCLUSIVE DISEASE 3 0.0004
628 SUDDEN DEATH 4 0.0004
629 MEDICATION ERROR 21 0.0004
630 PREMATURE DELIVERY 6 0.0004
631 BLOOD SODIUM DECREASED 7 0.0004
632 FIBROMYALGIA 9 0.0004
633 RED BLOOD CELL SEDIMENTATION RATE INCREASED 4 0.0004
634 NERVE INJURY 4 0.0004
635 OBSTRUCTIVE AIRWAYS DISORDER 4 0.0004
636 HYPERTENSIVE CRISIS 4 0.0004
637 UPPER GASTROINTESTINAL HAEMORRHAGE 6 0.0004
638 BLOOD CALCIUM DECREASED 4 0.0004
639 GASTRIC HAEMORRHAGE 4 0.0003
640 BLOOD MAGNESIUM DECREASED 3 0.0003
641 PYELONEPHRITIS 3 0.0003
642 FOETAL EXPOSURE DURING PREGNANCY 28 0.0003
643 VASCULITIS 4 0.0003
644 DYSSTASIA 10 0.0003
645 NIGHT SWEATS 11 0.0003
646 BLOOD IRON DECREASED 4 0.0003
647 BALANCE DISORDER 29 0.0003
648 PALLOR 9 0.0003
649 URINARY RETENTION 11 0.0003
650 TOXIC EPIDERMAL NECROLYSIS 5 0.0003
651 DEPRESSED LEVEL OF CONSCIOUSNESS 13 0.0003
652 SKIN LESION 9 0.0003
653 LUNG DISORDER 16 0.0003
654 RETINAL DETACHMENT 3 0.0003
655 OSTEONECROSIS OF JAW 8 0.0003
656 FAECES DISCOLOURED 7 0.0003
657 EXTRAPYRAMIDAL DISORDER 8 0.0003
658 DEMENTIA 9 0.0003
659 ILEUS 4 0.0003
660 APPENDICITIS 3 0.0003
661 TUBULOINTERSTITIAL NEPHRITIS 6 0.0003
662 DERMATITIS ALLERGIC 4 0.0003
663 BRAIN OEDEMA 4 0.0003
664 ABDOMINAL DISCOMFORT 53 0.0003
665 GASTRIC ULCER 6 0.0003
666 HAEMORRHAGE 33 0.0003
667 RESPIRATORY FAILURE 23 0.0003
668 CARDIAC ARREST 26 0.0003
669 RECALLED PRODUCT ADMINISTERED 3 0.0003
670 PULMONARY FIBROSIS 6 0.0003
671 PULMONARY OEDEMA 14 0.0003
672 GASTROINTESTINAL DISORDER 28 0.0003
673 ATELECTASIS 3 0.0003
674 HIATUS HERNIA 4 0.0003
675 VITAMIN D DEFICIENCY 3 0.0003
676 BONE PAIN 18 0.0003
677 PLATELET COUNT INCREASED 4 0.0003
678 KIDNEY INFECTION 6 0.0003
679 MUCOSAL INFLAMMATION 8 0.0003
680 DIABETES MELLITUS 23 0.0003
681 ACCIDENTAL OVERDOSE 11 0.0003
682 COGNITIVE DISORDER 14 0.0003
683 EMPHYSEMA 3 0.0003
684 BLOOD BILIRUBIN INCREASED 8 0.0003
685 EYELID PTOSIS 3 0.0003
686 OCULAR HYPERAEMIA 14 0.0003
687 DEPRESSION 67 0.0003
688 EPILEPSY 9 0.0003
689 MOTOR DYSFUNCTION 3 0.0003
690 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 2 0.0003
691 DRUG TOXICITY 4 0.0003
692 CHEST DISCOMFORT 30 0.0003
693 PAIN IN EXTREMITY 86 0.0003
694 FEMUR FRACTURE 9 0.0003
695 PROCEDURAL PAIN 8 0.0003
696 URINARY TRACT INFECTION 49 0.0003
697 EOSINOPHILIA 5 0.0003
698 ENCEPHALOPATHY 7 0.0003
699 DISSEMINATED INTRAVASCULAR COAGULATION 4 0.0003
700 INCONTINENCE 3 0.0003
701 SINUS TACHYCARDIA 4 0.0003
702 EPISTAXIS 21 0.0003
703 GASTROENTERITIS VIRAL 5 0.0003
704 MENTAL DISORDER 12 0.0003
705 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
706 ARRHYTHMIA 13 0.0003
707 BLOOD GLUCOSE FLUCTUATION 3 0.0003
708 PALPITATIONS 32 0.0003
709 TOOTH FRACTURE 3 0.0003
710 ANAPHYLACTIC SHOCK 7 0.0003
711 FOOT DEFORMITY 3 0.0003
712 VIRAL INFECTION 9 0.0003
713 CHEST PAIN 50 0.0003
714 NECK PAIN 15 0.0003
715 OSTEOPOROSIS 11 0.0003
716 NEPHROPATHY TOXIC 3 0.0003
717 HEPATIC CIRRHOSIS 5 0.0003
718 DYSARTHRIA 10 0.0003
719 HYPOCALCAEMIA 5 0.0003
720 DYSPHAGIA 25 0.0003
721 MYOCARDITIS 3 0.0003
722 NEPHROLITHIASIS 12 0.0003
723 NEOPLASM 3 0.0003
724 NIGHTMARE 9 0.0003
725 OSTEOARTHRITIS 11 0.0003
726 THROAT TIGHTNESS 7 0.0003
727 DELUSION 4 0.0003
728 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 6 0.0003
729 NERVOUS SYSTEM DISORDER 8 0.0003
730 PLATELET COUNT DECREASED 27 0.0003
731 ATAXIA 3 0.0003
732 CHOLECYSTITIS 3 0.0003
733 MACULAR DEGENERATION 3 0.0003
734 MOBILITY DECREASED 18 0.0003
735 HEPATIC ENZYME INCREASED 17 0.0002
736 ECZEMA 13 0.0002
737 PARAESTHESIA 39 0.0002
738 RASH 108 0.0002
739 TREMOR 41 0.0002
740 FLATULENCE 14 0.0002
741 CHOLELITHIASIS 8 0.0002
742 INJECTION SITE EXTRAVASATION 3 0.0002
743 RIB FRACTURE 5 0.0002
744 NEUTROPENIA 33 0.0002
745 LOSS OF CONSCIOUSNESS 31 0.0002
746 OVERDOSE 52 0.0002
747 GAIT DISTURBANCE 46 0.0002
748 FUNGAL INFECTION 8 0.0002
749 INTENTIONAL PRODUCT USE ISSUE 21 0.0002
750 INTESTINAL OBSTRUCTION 9 0.0002
751 TRANSIENT ISCHAEMIC ATTACK 8 0.0002
752 PNEUMONIA 76 0.0002
753 ERECTILE DYSFUNCTION 6 0.0002
754 PANCYTOPENIA 13 0.0002
755 SKIN ULCER 6 0.0002
756 DELIRIUM 8 0.0002
757 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 12 0.0002
758 CONSTIPATION 50 0.0002
759 FEELING HOT 14 0.0002
760 ORAL CANDIDIASIS 3 0.0002
761 GASTROINTESTINAL HAEMORRHAGE 19 0.0002
762 GYNAECOMASTIA 7 0.0002
763 LIMB DISCOMFORT 7 0.0002
764 EXPOSURE DURING PREGNANCY 14 0.0002
765 ISCHAEMIC STROKE 4 0.0002
766 QUALITY OF LIFE DECREASED 3 0.0002
767 RASH PAPULAR 5 0.0002
768 HYPOAESTHESIA 33 0.0002
769 GINGIVAL BLEEDING 3 0.0002
770 CELLULITIS 11 0.0002
771 PROSTATIC SPECIFIC ANTIGEN INCREASED 3 0.0002
772 RESPIRATORY DISTRESS 6 0.0002
773 COVID-19 38 0.0002
774 CONFUSIONAL STATE 35 0.0002
775 PERICARDIAL EFFUSION 5 0.0002
776 BRONCHITIS 16 0.0002
777 FEELING COLD 6 0.0002
778 HAEMOPTYSIS 6 0.0002
779 CARPAL TUNNEL SYNDROME 3 0.0002
780 IMPAIRED HEALING 7 0.0002
781 DEVICE OCCLUSION 3 0.0002
782 INFLAMMATION 11 0.0002
783 SKIN REACTION 3 0.0002
784 SEASONAL ALLERGY 3 0.0002
785 MUSCULOSKELETAL PAIN 11 0.0002
786 EYE PRURITUS 7 0.0002
787 POST PROCEDURAL COMPLICATION 4 0.0002
788 LOWER LIMB FRACTURE 4 0.0002
789 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 10 0.0002
790 GLAUCOMA 4 0.0002
791 MYELODYSPLASTIC SYNDROME 3 0.0002
792 MENTAL IMPAIRMENT 5 0.0002
793 FLUID OVERLOAD 3 0.0002
794 WEIGHT DECREASED 57 0.0002
795 MEMORY IMPAIRMENT 28 0.0002
796 RASH PRURITIC 11 0.0002
797 PULMONARY MASS 3 0.0002
798 HAEMORRHAGE INTRACRANIAL 3 0.0002
799 DEEP VEIN THROMBOSIS 13 0.0002
800 IRRITABILITY 12 0.0002
801 BLOOD POTASSIUM DECREASED 6 0.0002
802 HEART RATE DECREASED 7 0.0002
803 HEPATIC FAILURE 6 0.0002
804 HYPOXIA 7 0.0002
805 HYPOPHAGIA 5 0.0002
806 INCORRECT DOSE ADMINISTERED 44 0.0002
807 SWOLLEN TONGUE 6 0.0002
808 SPEECH DISORDER 10 0.0002
809 CYANOSIS 3 0.0002
810 AGITATION 14 0.0002
811 HALLUCINATION, VISUAL 4 0.0002
812 PNEUMOTHORAX 3 0.0002
813 CYSTITIS 6 0.0002
814 RASH ERYTHEMATOUS 9 0.0002
815 DYSPHONIA 11 0.0002
816 EATING DISORDER 4 0.0002
817 RECTAL HAEMORRHAGE 8 0.0002
818 RHINORRHOEA 12 0.0002
819 DRUG EFFECT DECREASED 10 0.0002
820 MALIGNANT NEOPLASM PROGRESSION 19 0.0002
821 BURNING SENSATION 13 0.0002
822 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 13 0.0002
823 ABDOMINAL DISTENSION 19 0.0002
824 CARDIAC DISORDER 17 0.0002
825 VISUAL ACUITY REDUCED 6 0.0002
826 LIP SWELLING 6 0.0002
827 WOUND 5 0.0002
828 HEART RATE IRREGULAR 4 0.0002
829 MULTIPLE ORGAN DYSFUNCTION SYNDROME 5 0.0002
830 SKIN IRRITATION 8 0.0002
831 CARDIAC FAILURE CONGESTIVE 14 0.0002
832 LOCAL SWELLING 3 0.0002
833 HEART RATE INCREASED 17 0.0002
834 HYPERHIDROSIS 22 0.0002
835 AMNESIA 11 0.0002
836 DISEASE PROGRESSION 20 0.0002
837 PRODUCTIVE COUGH 8 0.0002
838 FLUSHING 17 0.0002
839 DIABETIC KETOACIDOSIS 4 0.0002
840 SYNOVITIS 3 0.0002
841 OSTEOMYELITIS 3 0.0002
842 HYPERGLYCAEMIA 6 0.0002
843 CONJUNCTIVITIS 3 0.0002
844 AGRANULOCYTOSIS 3 0.0002
845 BACK PAIN 37 0.0002
846 BLOOD URINE PRESENT 3 0.0002
847 CONVULSION 9 0.0002
848 WHITE BLOOD CELL COUNT INCREASED 6 0.0002
849 CONTUSION 15 0.0002
850 UNRESPONSIVE TO STIMULI 4 0.0002
851 PHARMACEUTICAL PRODUCT COMPLAINT 4 0.0002
852 SKIN FISSURES 3 0.0002
853 EYE DISORDER 5 0.0002
854 DISABILITY 3 0.0002
855 UPPER RESPIRATORY TRACT INFECTION 7 0.0002
856 PRESCRIBED UNDERDOSE 3 0.0002
857 BLOOD GLUCOSE INCREASED 28 0.0001
858 CONDITION AGGRAVATED 45 0.0001
859 NEUTROPHIL COUNT DECREASED 6 0.0001
860 NEUROPATHY PERIPHERAL 14 0.0001
861 ACUTE HEPATIC FAILURE 2 0.0001
862 BLOOD GLUCOSE DECREASED 7 0.0001
863 ANAPHYLACTIC REACTION 8 0.0001
864 MOUTH ULCERATION 3 0.0001
865 OXYGEN SATURATION DECREASED 8 0.0001
866 HERPES ZOSTER 8 0.0001
867 PRURITUS GENERALISED 3 0.0001
868 FLUID RETENTION 7 0.0001
869 APATHY 2 0.0001
870 SINUSITIS 14 0.0001
871 FEBRILE NEUTROPENIA 9 0.0001
872 DRY MOUTH 11 0.0001
873 WHEEZING 8 0.0001
874 RENAL INJURY 4 0.0001
875 CATARACT 8 0.0001
876 DYSPEPSIA 13 0.0001
877 RHEUMATOID ARTHRITIS 15 0.0001
878 COLITIS 5 0.0001
879 DRUG ADMINISTRATION ERROR 4 0.0001
880 VISUAL IMPAIRMENT 16 0.0001
881 HAEMATOCHEZIA 7 0.0001
882 LOCALISED INFECTION 3 0.0001
883 ASTHMA 14 0.0001
884 STAPHYLOCOCCAL INFECTION 4 0.0001
885 WHITE BLOOD CELL COUNT DECREASED 13 0.0001
886 ANXIETY 34 0.0001
887 WITHDRAWAL SYNDROME 5 0.0001
888 GASTRIC CANCER 3 0.0001
889 DRUG INEFFECTIVE 155 0.0001
890 DRUG RESISTANCE 3 0.0001
891 RASH GENERALISED 3 0.0001
892 PULMONARY EMBOLISM 11 0.0001
893 DEVICE DISLOCATION 5 0.0001
894 DEAFNESS 3 0.0001
895 EAR INFECTION 3 0.0001
896 OFF LABEL USE 98 0.0001
897 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
898 PAIN 68 0.0001
899 LIMB INJURY 3 0.0001
900 WRONG TECHNIQUE IN DRUG USAGE PROCESS 4 0.0001
901 SUICIDAL IDEATION 10 0.0001
902 DIVERTICULITIS 3 0.0001
903 ARTHROPATHY 6 0.0001
904 HYPERSENSITIVITY 20 0.0001
905 EYE SWELLING 4 0.0001
906 RENAL DISORDER 5 0.0001
907 HALLUCINATION 8 0.0001
908 PAIN IN JAW 3 0.0001
909 FEELING ABNORMAL 25 0.0001
910 INFECTION 15 0.0001
911 MUSCULOSKELETAL STIFFNESS 9 0.0001
912 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
913 ABNORMAL BEHAVIOUR 4 0.0001
914 PRODUCT USE IN UNAPPROVED INDICATION 25 0.0001
915 ADVERSE DRUG REACTION 9 0.0001
916 DRY EYE 5 0.0001
917 ABORTION SPONTANEOUS 4 0.0001
918 SUICIDE ATTEMPT 6 0.0001
919 STOMATITIS 6 0.0001
920 NASOPHARYNGITIS 18 0.0001
921 LUNG NEOPLASM MALIGNANT 4 0.0001
922 OROPHARYNGEAL PAIN 9 0.0001
923 NERVOUSNESS 5 0.0001
924 DEPRESSED MOOD 5 0.0001
925 DYSGEUSIA 7 0.0001
926 HOT FLUSH 7 0.0001
927 TREATMENT NONCOMPLIANCE 5 0.0001
928 PRODUCT USE ISSUE 17 0.0001
929 EXPIRED PRODUCT ADMINISTERED 3 0.0001
930 BLISTER 5 0.0001
931 ARTHRITIS 7 0.0001
932 TOXICITY TO VARIOUS AGENTS 15 0.0001
933 LOWER RESPIRATORY TRACT INFECTION 4 0.0001
934 PRODUCT SUBSTITUTION ISSUE 5 0.0001
935 ADVERSE EVENT 8 0.0001
936 SEIZURE 10 0.0001
937 RASH MACULAR 3 0.0001
938 LYMPHADENOPATHY 3 0.0001
939 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 6 0.0001
940 PSORIASIS 11 0.0001
941 DISEASE RECURRENCE 4 0.0001
942 SKIN BURNING SENSATION 6 0.0001
943 SKIN EXFOLIATION 7 0.0001
944 INFLUENZA 9 0.0001
945 INTENTIONAL PRODUCT MISUSE 7 0.0001
946 AGGRESSION 4 0.0001
947 ANHEDONIA 2 0.0001
948 WEIGHT INCREASED 17 0.0001
949 INFUSION RELATED REACTION 5 0.0001
950 NEOPLASM MALIGNANT 5 0.0001
951 PSORIATIC ARTHROPATHY 3 0.0001
952 DYSKINESIA 3 0.0001
953 MIGRAINE 7 0.0001
954 ERYTHEMA 15 0.0001
955 PERIPHERAL SWELLING 11 0.0001
956 INJURY 5 0.0001
957 HYPOACUSIS 3 0.0001
958 EYE IRRITATION 4 0.0001
959 NASAL CONGESTION 4 0.0001
960 BLADDER CANCER 4 0.0001
961 ACCIDENTAL EXPOSURE TO PRODUCT 7 0.0001
962 MATERNAL EXPOSURE DURING PREGNANCY 6 0.0001
963 THROAT IRRITATION 3 0.0001
964 ILL-DEFINED DISORDER 4 0.0001
965 URTICARIA 11 0.0001
966 INJECTION SITE BRUISING 5 0.0001
967 ALOPECIA 12 0.0001
968 COMPLETED SUICIDE 5 0.0001
969 THERAPY CESSATION 3 0.0001
970 UNDERDOSE 4 0.0001
971 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
972 UNEVALUABLE EVENT 4 0.0001
973 LETHARGY 3 0.0001
974 SURGERY 3 0.0001
975 DEATH 43 0.0000
976 THERAPEUTIC RESPONSE DECREASED 3 0.0000
977 INFLUENZA LIKE ILLNESS 4 0.0000
978 INTENTIONAL OVERDOSE 3 0.0000
979 DRUG WITHDRAWAL SYNDROME 4 0.0000
980 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 8 0.0000
981 INJECTION SITE REACTION 3 0.0000
982 INJECTION SITE ERYTHEMA 5 0.0000
983 PRODUCT QUALITY ISSUE 5 0.0000
984 DRUG DOSE OMISSION 6 0.0000
985 TREATMENT FAILURE 3 0.0000
986 INJECTION SITE PAIN 11 0.0000
987 PRODUCT DOSE OMISSION ISSUE 9 0.0000
988 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6 0.0000
989 EMOTIONAL DISTRESS 3 0.0000
990 DRY SKIN 3 0.0000
991 DRUG DEPENDENCE 3 0.0000